Becton Dickinson (BDX) Cash & Current Investments (2009 - 2026)
Becton Dickinson (BDX) reported Cash & Current Investments of $1.0 billion for Q1 2026, up 35.88% year-over-year from $747.0 million in Q1 2025, and up 35.15% quarter-over-quarter from $751.0 million in Q4 2025.
Becton Dickinson (BDX) Cash & Current Investments (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Cash & Current Investments data on file, last reported at $1.0 billion in Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $1.0 billion, up 35.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 35.88% YoY), and the FY2025 annual result was $575.0 million, down 73.4% from the prior year.
- Cash & Current Investments advanced to $1.0 billion in Q1 2026 per BDX's latest filing, from $751.0 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $4.5 billion in Q2 2024 and troughed at $575.0 million in Q3 2025.
- A 5-year average of $1.6 billion and a median of $1.0 billion in 2023 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2024 and 2025: Cash & Current Investments jumped 338.18% in 2024, then sank 82.24% in 2025.
- A 5-year view of Cash & Current Investments shows it stood at $745.0 million in 2022, then surged by 58.66% to $1.2 billion in 2023, then slumped by 38.41% to $728.0 million in 2024, then gained by 3.16% to $751.0 million in 2025, then jumped by 35.15% to $1.0 billion in 2026.
- Business Quant data shows BDX's Cash & Current Investments at $1.0 billion in Q1 2026, $751.0 million in Q4 2025, and $575.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 4.52 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.02 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.24 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.66 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 521.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.06 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.02 Bn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 229.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.02 Bn |
| Dec 31, 2025 | 751.00 Mn |
| Sep 30, 2025 | 575.00 Mn |
| Jun 30, 2025 | 797.00 Mn |
| Mar 31, 2025 | 747.00 Mn |
| Dec 31, 2024 | 728.00 Mn |
| Sep 30, 2024 | 2.16 Bn |
| Jun 30, 2024 | 4.49 Bn |
| Mar 31, 2024 | 2.39 Bn |
| Dec 31, 2023 | 1.18 Bn |
| Sep 30, 2023 | 1.48 Bn |
| Jun 30, 2023 | 1.02 Bn |
| Mar 31, 2023 | 1.99 Bn |
| Dec 31, 2022 | 745.00 Mn |
| Sep 30, 2022 | 1.01 Bn |
| Jun 30, 2022 | 2.57 Bn |
| Mar 31, 2022 | 3.16 Bn |
| Dec 31, 2021 | 1.91 Bn |
| Sep 30, 2021 | 2.39 Bn |
| Jun 30, 2021 | 3.28 Bn |